[New facility] Oxford nanopore MinION sequencing platform

Jung Lab

2020년 1월 31일

1분 분량

최종 수정일: 2020년 4월 20일

New devices have been set up in our lab for nanopore sequencing studies. An Oxford nanopore MinION sequencer and a computer system with GPU have been installed for reliable sequencing and fast analysis.

최근 게시물

전체 보기

[New publication] Microbiome–Genome Crosstalk in Colorectal Cancer: Colibactin Signatures and Fusobacterium nucleatum in Epidemiology, Driver Selection, and Translation

[New publication] Targeted Next-Generation Sequencing in Drug-Resistant Tuberculosis: WHO Guidance and Practical Implementation Priorities

Our new paper has been published in Biomedicines. Sungwon Jung. "Targeted Next-Generation Sequencing in Drug-Resistant Tuberculosis: WHO Guidance and Practical Implementation Priorities" Biomedicines,

[New publication] From CMS to iCMS/IMF: Developing Roadmap to Precision Therapy in Colorectal Cancer

Our new paper has been published in International Journal of Molecular Sciences. Sungwon Jung. "From CMS to iCMS/IMF: Developing Roadmap to Precision Therapy in Colorectal Cancer" International Journa

[New publication] Microbiome–Genome Crosstalk in Colorectal Cancer: Colibactin Signatures and Fusobacterium nucleatum in Epidemiology, Driver Selection, and Translation

Our new paper has been published in International Journal of Molecular Sciences. Sungwon Jung. "Microbiome–Genome Crosstalk in Colorectal Cancer: Colibactin Signatures and Fusobacterium nucleatum in Epidemiology, Driver Selection, and Translation" International Journal of Molecular Sciences, 27(4):2068, 2026.

Jung Lab

4월 2일1분 분량

[New publication] Targeted Next-Generation Sequencing in Drug-Resistant Tuberculosis: WHO Guidance and Practical Implementation Priorities

Jung Lab

1월 15일1분 분량

댓글

[New publication] Microbiome–Genome Crosstalk in Colorectal Cancer: Colibactin Signatures and Fusobacterium nucleatum in Epidemiology, Driver Selection, and Translation

[New publication] Targeted Next-Generation Sequencing in Drug-Resistant Tuberculosis: WHO Guidance and Practical Implementation Priorities